Ivantis Raises US$46.5 Million in Series B Financing
Ivantis, developer of the novel Hydrus® Microstent device designed to lower eye pressure for laucoma patients, announced today that it secured an additional US$14 MM from Vertex Ventures and GBS Ventures in the final close of its Series B financing. This additional US$14 MM takes the total Series B to US$46.5 MM, making it one of the largest medical device financings of the past year.
"$100m fund to help start-ups survive ‘valley of death’ gap" by Grace Chng
Vertex announced the launch of a new S$100 million fund to help local start-ups in Singapore. This fund aims to help start-ups grow and survive the “valley of death” finance gap in the early stages of a start-up. The fund will primarily invest in companies in the infocomm technology and healthcare sectors with investment size ranging from US$1 million to US$10 million for each investment.